Literature DB >> 35879914

Readjustment of Capsule Endoscopy Protocols to the COVID-19 Pandemic in a Portuguese Tertiary Center.

João Correia1, Ana Ponte1, Catarina Gomes1, Edgar Afecto1, Maria Manuela Estevinho1, Adélia Rodrigues1, Rolando Pinho1, João Carvalho1.   

Abstract

BACKGROUND: The prevention of severe acute respiratory syndrome corona virus 2 transmission implies several social distancing mea- sures, imposing a change in the protocols of several hospital departments. Capsule endoscopy protocols changes were implemented and evaluated in a Portuguese tertiary center.
METHODS: The authors compared pre-pandemic and peri-pandemic protocols, the latter favoring social distancing, used in MiroCam (IntroMedic, Seoul, Korea) and PillCam Crohn (Medtronic, Minneapolis, Minn, USA) capsule endoscopy, in a Gastroenterology Department of a tertiary center. All capsule endoscopy performed in outpatients between February 2018 and September 2020 was included. The authors compared significant lesions detection rate, completeness of procedure, adequate bowel preparation, complications rate, and patient satisfaction (through a brief phone call survey) among the protocols.
RESULTS: This study included 70 MiroCam CE and 43 PillCam Crohn capsule endoscopy. No statistically significant differences concern- ing performance measures and patients satisfaction were found among the pre-pandemic protocol and the peri-pandemic protocol in MiroCam capsule endoscopy. Conversely, in PillCam Crohn capsule endoscopy, the rate of complete exams was significantly inferior in the peri-pandemic protocol (84.8% vs 50.0%, P = .036), with no other statistically significant differences in the remaining parameters.
CONCLUSION: The performance measures and patient satisfaction were similar among the protocols analyzed for MiroCam capsule endoscopy. Thus, the readjustment of this capsule endoscopy system, which favors a reduction in hospital stay, appears to be a good alternative to the former protocols in this pandemic era. In contrast, the rate of complete exams was significantly inferior in the adapted protocol to the pandemic era for PillCam Crohn capsule endoscopy, disfavoring its maintenance in the clinical practice.

Entities:  

Mesh:

Year:  2022        PMID: 35879914      PMCID: PMC9404681          DOI: 10.5152/tjg.2022.21574

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.555


  16 in total

1.  Use of an external real-time image viewer coupled with prespecified actions enhanced the complete examinations for capsule endoscopy.

Authors:  Akiko Shiotani; Keisuke Honda; Makiko Kawakami; Ryuji Nishi; Takahisa Murao; Manabu Ishii; Hiroshi Matsumoto; Hiroaki Kusunoki; Jiro Hata; Ken Haruma
Journal:  J Gastroenterol Hepatol       Date:  2011-08       Impact factor: 4.029

Review 2.  Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) Technical Review.

Authors:  Emanuele Rondonotti; Cristiano Spada; Samuel Adler; Andrea May; Edward J Despott; Anastasios Koulaouzidis; Simon Panter; Dirk Domagk; Ignacio Fernandez-Urien; Gabriel Rahmi; Maria Elena Riccioni; Jeanin E van Hooft; Cesare Hassan; Marco Pennazio
Journal:  Endoscopy       Date:  2018-03-14       Impact factor: 10.093

3.  Massive impact of coronavirus disease 2019 pandemic on gastroenterology and hepatology departments and doctors in Spain.

Authors:  Javier Crespo; Carlos Fernández Carrillo; Paula Iruzubieta; Marta Hernández-Conde; Laura Rasines; Francisco Jorquera; Agustín Albillos; Rafael Bañares; Pedro Mora; Inmaculada Fernández Vázquez; Manuel Hernández-Guerra; Juan Turnes; José Luis Calleja
Journal:  J Gastroenterol Hepatol       Date:  2020-12-14       Impact factor: 4.029

4.  A validation study of 3 grading systems to evaluate small-bowel cleansing for wireless capsule endoscopy: a quantitative index, a qualitative evaluation, and an overall adequacy assessment.

Authors:  Corey Brotz; Neilanjan Nandi; Mitchell Conn; Constantine Daskalakis; Michael DiMarino; Anthony Infantolino; Leo C Katz; Theodore Schroeder; David Kastenberg
Journal:  Gastrointest Endosc       Date:  2008-10-11       Impact factor: 9.427

5.  Risk factors for incomplete small-bowel capsule endoscopy.

Authors:  Jessie Westerhof; Rinse K Weersma; Jan J Koornstra
Journal:  Gastrointest Endosc       Date:  2008-08-08       Impact factor: 9.427

6.  Restarting gastrointestinal endoscopy in the deceleration and early recovery phases of COVID-19 pandemic: Guidance from the British Society of Gastroenterology.

Authors:  Colin J Rees; James E East; Kofi Oppong; Andrew Veitch; Mark McAlindon; John Anderson; Bu Hayee; Cathryn Edwards; Alastair McKinlay; Ian Penman
Journal:  Clin Med (Lond)       Date:  2020-06-09       Impact factor: 2.659

7.  A guide for assessing the clinical relevance of findings in small bowel capsule endoscopy: analysis of 8064 answers of international experts to an illustrated script questionnaire.

Authors:  R Leenhardt; A Koulaouzidis; D McNamara; M Keuchel; R Sidhu; M E McAlindon; J C Saurin; R Eliakim; I Fernandez-Urien Sainz; J N Plevris; G Rahmi; E Rondonotti; B Rosa; C Spada; E Toth; C Houdeville; C Li; M Robaszkiewicz; P Marteau; X Dray
Journal:  Clin Res Hepatol Gastroenterol       Date:  2021-01-28       Impact factor: 2.947

Review 8.  Colon capsule endoscopy: an innovative method for detecting colorectal pathology during the COVID-19 pandemic?

Authors:  C MacLeod; P Wilson; A J M Watson
Journal:  Colorectal Dis       Date:  2020-06-02       Impact factor: 3.788

9.  Returning to digestive endoscopy normality will be slow and must include novelty and telemedicine.

Authors:  Anastasios Koulaouzidis; Wojciech Marlicz; Hagen Wenzek; George Koulaouzidis; Rami Eliakim; Ervin Toth
Journal:  Dig Liver Dis       Date:  2020-06-19       Impact factor: 4.088

10.  Collateral Casualties of COVID-19.

Authors:  George Koulaouzidis; Dafni Charisopoulou; Anastasios Koulaouzidis
Journal:  J Am Coll Cardiol       Date:  2021-05-25       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.